In general, this finding is in line with the previous literature on GR immunostaining in cancer (summarized in Supplementary Figure S2 [20,21,22,24,26,27,29,30,31,34,35,36,40,46,47,50,51,52,53,54,55,56,57,58] although published data were controversial for several entities. The gene discussed is NR3C1; the disease is cancer.